Pulse Biosciences, Inc.PLSENASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+170.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+170.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
19.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2643.82 | - |
| 2024 | 0.00 | - |
| 2023 | 0.00 | -100.0% |
| 2022 | 134.29 | -54.0% |
| 2021 | 292.06 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |